Alembic pharmaceuticals Ltd on Friday announced that it has received approval from the US Food & Drug Administration (USFDA) for a generic drug used to treat overactive bladder (OAB) in
News
Jan 6, 2023
Jan 2, 2025
Dec 31, 2024
